Recombinant Human Interleukin-11 Combination Low-dose Rituximab in Immune Thrombocytopenia

NCT01317966 · clinicaltrials.gov ↗

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No eligible patients were enrolled.

Conditions

Purpura, Thrombocytopenic, Idiopathic

Interventions

DRUG: rhIL-11

Sponsor

Ming Hou

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]